AzTrials
AzTrials

Pediatric ObesityRO1NCT03341247

Brain Mechanisms of Overeating in Children

An observational study of Pediatric Obesity and Inhibition, run by Penn State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed research will follow healthy weight children who vary by family risk for obesity to identify the neurobiological and appetitive traits that are implicated in overeating and weight gain during the critical pre-adolescent period. Read more about this study

Who is it for?
Ages 7 to 8 yearsHealthy volunteers can take part
Conditions the study is for
Pediatric Obesity, Inhibition, Decision Making
How many people
254 participants
Where
1 siteUnited States
Study dates
31 Jan 2018to 20 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 8 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Parents and their 7-8 year old children in Centre County, Pennsylvania and surrounding areas.

Who may be able to join

  • Child is in good health based on parental self-report
  • Child has no learning disabilities (e.g., ADHD)
  • Child has no diagnosed psychological or medical conditions/devices, or metal in/on the body that may impact comfort or safety in the fMRI (e.g., anxiety, insulin pump)
  • Child is not on any medications known to influence body weight, taste, food intake, behavior, or blood flow
  • Child is not claustrophobic
  • Child is between the ages of 7-8 years-old at enrollment
Show all 9Show fewer
  • Child's immediate family members have not been diagnosed with a psychological disorder, including depression, anxiety, schizophrenia, etc.
  • Child's biological mother and biological father have a body mass index either between 18.5 - 25 kg/m2 (low-risk group) or biological mother has a body mass index greater than or equal to 30 kg/m2 and biological father has a body mass index greater than or equal to 25 kg/m2 (high-risk group)
  • Child's parent participating in study must be available to attend visits with child

Who cannot join

  • Child is not in good health based on parent self-report
  • Child has any learning disabilities (e.g., ADHD)
  • Child has any psychological or medical conditions/devices that may impact comfort in the fMRI (e.g., anxiety, insulin pump)
  • Child is taking any medications known to influence body weight, taste, food intake, behavior, or blood flow
  • Child is claustrophobic
  • Child is less than 7 or greater than 8 years-old at enrollment
Show all 11Show fewer
  • Child has any immediate family members diagnosed with a psychological disorder, including depression, anxiety, schizophrenia, etc.
  • Child's biological mother or biological father's body mass index do not fit into the parameters for either group (both biological parents < 18.5 for low-risk group or biological mother is < 30 and biological father is < 25 for high-risk group)
  • Child's parent participating in study is not available to attend visits with child
  • Child is blue/green colorblind
  • Child is not fluent in the English language

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Pennsylvania State University

    University Park, Pennsylvania, 16802

Other trials in United States

About this study

The proposed research will follow healthy weight children who vary by family risk for obesity to identify the neurobiological and appetitive traits that are implicated in overeating and weight gain during the critical pre-adolescent period. The investigator's central hypothesis is that increased intake from large portions of energy dense foods is due in part to reduced activity in brain regions implicated in inhibitory control and decision making, combined with increased activity in reward processing pathways. To test this hypothesis, the investigators will recruit 120 healthy weight children, aged 7-8 years, at two levels of obesity risk (i.e., 60 high-risk and 60 low-risk) based on parent weight status. This will result in 240 participants: 120 children and their parents.

Read the detailed description

In aim one, the investigators will use functional magnetic resonance imaging to characterize the brain regions which are activated in response to food portion size and compare these regions between high- and low-risk children.

Second, the investigators will determine the relationship between brain response to visual portion size cues and measured food intake when portions are increased in the laboratory.

Third, the investigators will determine the relationship between brain response to large portions and other validated measures of overeating, including satiety responsiveness and the amount of calories children consumed from high calorie snacks when they are not hungry (i.e., eating in the absence of hunger).

Fourth, the investigators will conduct follow-up visits one year after baseline to determine the extent to which baseline brain and behavioral responses to portion size predict gains in adiposity assessed by anthropometrics (body weight, height, and dual-energy x-ray absorptiometry).

Secondary study endpoints include the relationship between child behavioral and brain response to food portion size and physical activity assessed by accelerometry and questionnaires, inhibitory control assessed by a stop signal test, reward-related design making assessed by a computer task, working memory assessed by an N-back task loss of control eating, child sleep, child working memory, child meal microstructure assessed by observational meal coding, parent rated eating behaviors, and parental feeding practices.

Keywords
Obesity, Portion Size Effect, fMRI, Functional Magnetic Resonance Imaging, Inhibition, Decision Making, Satiety Responsiveness, Anthropometrics, DXA, Reward Processing, Working Memory, Meal microstructure
Medical subject headings
Pediatric Obesity, Inhibition, Psychological, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03341247
Study groupRoleWhat they receive
Low-risk of obesityChildren whose biological mother and biological father have a body mass index between 18.5 - 25 kg/m2.
High-risk of obesityChildren whose biological mother has a body mass index greater than or equal to 30 kg/m2 and whose biological father have a body mass index greater than or equal to 25 kg/m2.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain Responses to Portion Size

    The investigators will use functional magnetic resonance imaging to characterize the brain regions which are activated in response to food portion size and compare these regions between high- and low-risk children.

    Measured: baseline

  2. Food Intake Relationship to Portion Size

    The investigators will determine the relationship between brain response to visual portion size cues and measured food intake when portions are increased in laboratory meals.

    Measured: baseline

  3. The Change in DXA analysis of child adiposity after 1 year

    The investigators will determine the extent to which baseline brain and behavioral responses to portion size predict gains in adiposity assessed by anthropometrics (body weight, height, and dual-energy x-ray absorptiometry). Body weight (kg) and Height (m) will be aggregated to report BMI in kg/m^2.

    Measured: From baseline visit to 1 year later

Secondary outcomes (6)
  1. Brain Response Relationships

    The investigators will determine the relationship between brain response to large portions and other validated measures of overeating, including satiety responsiveness and the amount of calories children consumed from high calorie snacks when they are not hungry (i.e., eating in the absence of hunger).

    Measured: baseline

  2. Inhibitory control assessed by a Stop Signal test

    An additional endpoint includes the relationship between child behavioral and brain response to food portion size and Inhibitory control assessed by a Stop Signal test.

    Measured: baseline

  3. Reward-related design

    Reward-related design making assessed by a computer task.

    Measured: baseline and 1 year later

  4. Working memory

    Working memory assessed by an N-back task.

    Measured: baseline and 1 year later

  5. Meal microstructure

    Meal microstructure assessed by observational meal coding.

    Measured: baseline and 1 year later

  6. Eating in the absence of hunger

    Assessing child eating in the absence of hunger by buffet meal intake.

    Measured: baseline and 1 year later

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2017
  2. Study start31 Jan 2018
  3. Primary completion20 Jun 2023
  4. Study completion20 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
254 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03341247
Sponsor's protocol ID
RO1 Study
Acronym
RO1
Status last verified
Dec 2023
First submitted
11 Oct 2017
Last updated
3 Jan 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: De-identified data will be shared with other investigators by special request made by email to the PI (Kathleen L. Keller klk37@psu.edu). For investigators who request use of the data, we will request acknowledgement of our research group and Penn State University in any public presentation of the results obtained from this study.

Publications

  • Burger KS, Stice E. Variability in reward responsivity and obesity: evidence from brain imaging studies. Curr Drug Abuse Rev. 2011 Sep;4(3):182-9. doi: 10.2174/1874473711104030182.

    PubMed 21999692
  • Bruce AS, Martin LE, Savage CR. Neural correlates of pediatric obesity. Prev Med. 2011 Jun;52 Suppl 1:S29-35. doi: 10.1016/j.ypmed.2011.01.018. Epub 2011 Feb 1.

    PubMed 21291906
  • De Silva A, Salem V, Matthews PM, Dhillo WS. The use of functional MRI to study appetite control in the CNS. Exp Diabetes Res. 2012;2012:764017. doi: 10.1155/2012/764017. Epub 2012 May 8.

    PubMed 22719753
  • French SA, Mitchell NR, Wolfson J, Harnack LJ, Jeffery RW, Gerlach AF, Blundell JE, Pentel PR. Portion size effects on weight gain in a free living setting. Obesity (Silver Spring). 2014 Jun;22(6):1400-5. doi: 10.1002/oby.20720. Epub 2014 Feb 19.

    PubMed 24510841
  • Grammer JK, Carrasco M, Gehring WJ, Morrison FJ. Age-related changes in error processing in young children: a school-based investigation. Dev Cogn Neurosci. 2014 Jul;9:93-105. doi: 10.1016/j.dcn.2014.02.001. Epub 2014 Feb 11.

    PubMed 24631799
  • Morrell, J. (1999). The Infant Sleep Questionnaire: A new tool to assess infant sleep problems for clinical and research purposes. Child Psychology and Psychiatry Review 4, 20-26.

  • Tetley A, Brunstrom J, Griffiths P. Individual differences in food-cue reactivity. The role of BMI and everyday portion-size selections. Appetite. 2009 Jun;52(3):614-620. doi: 10.1016/j.appet.2009.02.005. Epub 2009 Feb 25.

    PubMed 19501758
  • Tanner, J.M. (1962). Growth at adolescence.(Oxford: Blackwell Scientific Publications).

  • Bhat YR, Keller KL, Brick TR, Pearce AL. ByteTrack: a deep learning approach for bite count and bite rate detection using meal videos in children. Front Nutr. 2025 Oct 3;12:1610363. doi: 10.3389/fnut.2025.1610363. eCollection 2025.

    PubMed 41112744
  • Neuwald NV, Pearce AL, Cunningham PM, Setzenfand MN, Koczwara L, Rolls BJ, Keller KL. Food switching at a meal is positively associated with change in adiposity among children at high-familial risk for obesity. Appetite. 2025 Apr 1;208:107915. doi: 10.1016/j.appet.2025.107915. Epub 2025 Feb 25.

    PubMed 40010570
  • Bhat YR, Rolls BJ, Wilson SJ, Rose E, Geier CF, Fuchs B, Garavan H, Keller KL. Eating in the Absence of Hunger Is a Stable Predictor of Adiposity Gains in Middle Childhood. J Nutr. 2024 Dec;154(12):3726-3739. doi: 10.1016/j.tjnut.2024.10.008. Epub 2024 Oct 10.

    PubMed 39393498
  • Keller KL, Pearce AL, Fuchs B, Rolls BJ, Wilson SJ, Geier CF, Rose E, Garavan H. PACE: a Novel Eating Behavior Phenotype to Assess Risk for Obesity in Middle Childhood. J Nutr. 2024 Jul;154(7):2176-2187. doi: 10.1016/j.tjnut.2024.05.019. Epub 2024 May 23.

    PubMed 38795747
  • Neuwald NV, Pearce AL, Cunningham PM, Koczwara L, Setzenfand MN, Rolls BJ, Keller KL. Switching between foods is reliably associated with intake across eating events in children. Appetite. 2024 Jun 1;197:107325. doi: 10.1016/j.appet.2024.107325. Epub 2024 Mar 26.

    PubMed 38548135

Questions about this trial

What is this clinical trial studying?

An observational study of Pediatric Obesity and Inhibition, run by Penn State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain Responses to Portion Size (time frame: baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03341247, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in